VITR.ST
Vitrolife AB
Price:  
103.90 
SEK
Volume:  
245,638.00
Sweden | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VITR.ST EV/EBITDA

-12.6%
Upside

As of 2026-04-16, the EV/EBITDA ratio of Vitrolife AB (VITR.ST) is 17.91. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VITR.ST's latest enterprise value is 14,869.25 mil SEK. VITR.ST's TTM EBITDA according to its financial statements is 830.00 mil SEK. Dividing these 2 quantities gives us the above VITR.ST EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 9.7x - 18.0x 14.8x
Forward P/E multiples 13.4x - 20.2x 16.8x
Fair Price 53.56 - 118.03 90.79
Upside -48.4% - 13.6% -12.6%
103.90 SEK
Stock Price
90.79 SEK
Fair Price

VITR.ST EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-04-16 18.62
2026-04-15 18.34
2026-04-14 17.91
2026-04-13 17.16
2026-04-10 16.74
2026-04-09 16.51
2026-04-08 16.50
2026-04-07 16.36
2026-04-02 16.10
2026-04-01 16.66
2026-03-31 16.34
2026-03-30 15.91
2026-03-27 15.97
2026-03-26 16.11
2026-03-25 15.65
2026-03-24 15.23
2026-03-23 15.48
2026-03-20 15.31
2026-03-19 15.31
2026-03-18 15.92
2026-03-17 16.14
2026-03-16 16.33
2026-03-13 16.18
2026-03-12 16.06
2026-03-11 16.30
2026-03-10 16.38
2026-03-09 15.98
2026-03-06 16.24
2026-03-05 16.22
2026-03-04 16.25
2026-03-03 16.03
2026-03-02 16.12
2026-02-27 16.53
2026-02-26 16.09
2026-02-25 15.74
2026-02-24 15.53
2026-02-23 15.63
2026-02-20 15.75
2026-02-19 15.81
2026-02-18 15.37
2026-02-17 15.52
2026-02-16 15.55
2026-02-13 15.60
2026-02-12 14.99
2026-02-11 14.94
2026-02-10 15.58
2026-02-09 15.54
2026-02-06 15.78
2026-02-05 15.60
2026-02-04 15.48